Developer docs
API playgroundTry for free, no card

Search company profiles

Novus Biologicals

Full company profile

uuid000b6hn

Namestring
Novus Biologicals
Legal namestring
Novus Biologicals, LLC
Websiteurl
novusbio.com
Company typeenum
Private
Founded yearint
1996
Descriptiontext

Novus Biologicals, LLC is a Colorado-based life sciences research reagents company that operates as a wholly-owned brand of Bio-Techne, a diversified life sciences conglomerate. The company sells more than 100,000 products—anchored by antibodies and expanded across kits, proteins, peptides, lysates, cell lines, inhibitors, and activators—directly to researchers through its e-commerce website novusbio.com. The website is scheduled to be retired on August 17, 2026, with all products and services migrating to the parent company's R&D Systems platform at rndsystems.com. Its primary customer base is academic and research institutions, with secondary serving pharmaceutical/biotech companies and hospital/clinical laboratories.

The company's technical differentiation rests on two pillars: recombinant monoclonal antibody production technology covering 8,000+ products against 1,600+ unique targets, which immortalizes antibody sequences for batch-to-batch consistency, and the Five Pillars of Antibody Validation framework incorporating genetic knockout validation, orthogonal validation, independent antibody verification, tagged expression, and biological validation in accordance with International Working Group for Antibody Validation recommendations. Its 85,000+ conjugated antibodies cover 7,400+ targets with 25+ fluorescent and enzymatic labels, and Lightning-Link kits allow researchers to label primary antibodies in under 30 seconds hands-on time. Supporting research tools include the Spectra Viewer, Flow Cytometry Panel Builder, and Laverne bioinformatics explorer.

Commercially, Novus operates a direct-to-consumer e-commerce model complemented by phone and email sales support, an Antibody Concierge service, a global distributor network, and custom and bulk antibody production services. Revenue is generated through one-time catalog sales of research reagents with quote-based pricing that is not publicly disclosed, and products are backed by a 100% quality guarantee offering free replacement or refund. Marketing is content-led, relying on a scientific blog, free handbooks, on-demand webinars, faculty and postdoc interview series, and rewards programs (Review Rewards, Innovator's Reward, Publication Rewards, Scholarship Program). The company serves a global market via distributors, with explicit geographic focus on North America and Europe.

Short descriptiontext

Novus Biologicals, a Bio-Techne-owned brand, sells 100,000+ life science research reagents—primarily antibodies, kits, and proteins—directly to academic, pharmaceutical, and clinical researchers worldwide, with the catalog scheduled to migrate to rndsystems.com by August 2026.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
51–100
akta.pro rankint
HeadquartersLittleton, United States
HQ citystring
Littleton
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
research antibodies, life science reagents, recombinant monoclonal antibodies, ELISA kits, antibody validation
Industry3 codes
1Reagents, Chemicals & Assay Kits (Buffers, Antibodies, ELISA, Enzymes)
CodeHLAGAIAIPrimaryYes
2Microscopy, Imaging & Flow Cytometry Instruments
CodeHLAGAIAEPrimaryNo
3Cell-Based & Potency Assays (Bioassays)
CodeHLAGADAHPrimaryNo
NAICS code2 codes
  • Medical, Dental, and Hospital Equipment and Supplies Merchant Wholesalers423450
  • Medical, Dental, and Hospital Equipment and Supplies Merchant Wholesalers42345
SIC code2 codes
  • Wholesale-Medical, Dental & Hospital Equipment & Supplies5047
  • Services-Commercial Physical & Biological Research8731
Product category
Life Science Research Reagents
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model1 record
1Research Reagent Product Sales
TypeOne Time License
Description

Sale of antibodies, kits, proteins, peptides, lysates, cell lines, inhibitors, activators, and support products for research applications including ELISA, flow cytometry, Western blotting, immunohistochemistry, and immunocytochemistry.

novusbio.com
Marketing channels8 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Supply Chain, Technology or R&D, Personnel, Marketing or Sales, Operations
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Core offering1 text field

Novus Biologicals manufactures and distributes a catalog of more than 100,000 life science research reagents — chiefly antibodies (primary, secondary, conjugated, recombinant monoclonal, isotype control, KO-validated), proteins and peptides, ELISA kits, flow cytometry kits, ChIP kits, antibody labeling kits, lysates, cell lines, exosome isolation products, inhibitors/activators, IHC tissue slides, and tissue microarrays — sold to researchers through e-commerce, phone/email support, an international distributor network, and custom/bulk ordering services.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 3 values shown
  • 85,000+ conjugated antibodies for over 7,400 targets
+2 more records
Product overview1 text field

Novus Biologicals is a life science reagents company offering over 100,000 products for research. The portfolio centers on antibodies—including primary antibodies, conjugated antibodies, recombinant monoclonals, secondary antibodies, and isotype controls—alongside proteins and peptides, ELISA and assay kits, and tissue products. Support offerings include exosome isolation tools, flow cytometry beads, IHC tissue slides, and tissue microarrays. Research tools include the Novus Spectra Viewer for fluorescent probe selection, Flow Cytometry Panel Builder for panel design, and Laverne bioinformatics explorer for gene/pathway/disease research. The company also provides custom/bulk ordering services and scientific resources including handbooks, protocols, webinars, and technical support. Products are backed by a 100% guarantee.

Product and service26 records
1Primary Antibodies
CategoryAntibodies
Description

Monoclonal and polyclonal antibodies for detection of more than 7,400 targets, available in unconjugated and conjugated formats for research applications.

2Conjugated Antibodies
CategoryAntibodies
Description

Over 85,000 primary antibodies directly conjugated to more than 25 fluorescent or enzymatic labels including Alexa Fluor, PE, FITC, and Janelia Fluor dyes for flow cytometry, ICC, IHC, and ELISA applications.

3Recombinant Monoclonal Antibodies
CategoryAntibodies
Description

Over 8,000 recombinant antibody products covering more than 1,600 unique targets, produced via hybridoma conversion and B-cell cloning with immortalized sequences for batch-to-batch consistency and engineerability.

4Secondary Antibodies
CategoryAntibodies
Description

Secondary antibodies for detection and signal amplification in immunoassay applications.

5Isotype Control Antibodies
CategoryAntibodies
Description

Isotype control antibodies for accurate gating and background signal control in flow cytometry and other applications.

6Sample Size Antibodies
CategoryAntibodies
Description

Smaller antibody quantities intended for pilot studies, testing new applications, or working with limited sample volumes.

7Antibody Packs
CategoryAntibodies
Description

Pre-configured antibody sampler packs containing multiple antibodies for related targets or pathway studies.

8Antibody Pairs
CategoryAntibodies
Description

Matched antibody pairs optimized for sandwich ELISA assays, including capture and detection antibodies.

9KO Validated Antibodies
CategoryAntibodies
Description

Antibodies validated using CRISPR-Cas9 genetic knockout cell lines to ensure specificity and reproducibility.

10Proteins and Peptides
CategoryProteins and Peptides
Description

Recombinant proteins, native proteins, and synthetic peptides including biologically active proteins for bioactivity assays.

11Blocking Peptides
CategoryProteins and Peptides
Description

Peptides used for antibody blocking experiments to verify antibody specificity in immunostaining applications.

12ELISA Kits
CategoryAssay Kits
Description

Complete ELISA kits for quantitative detection of proteins and biomarkers in various sample types.

13Flow Cytometry Kits
CategoryAssay Kits
Description

Pre-configured kits for flow cytometry applications, including cell surface and intracellular staining panels.

14Lightning-Link Antibody Labeling Kits
CategoryAssay Kits
Description

Antibody conjugation kits enabling labeling of primary antibodies with more than 40 enzymatic, fluorescent, or biotin labels in under 30 seconds hands-on time.

15ChIP Kits
CategoryAssay Kits
Description

Chromatin immunoprecipitation kits for studying protein-DNA interactions and epigenetic modifications.

16Lysates and Cell Lines
CategoryCell Biology Reagents
Description

Cell lysates and stem cell lines for research applications, including stem cell research.

17Exosome Isolation Products
CategoryCell Biology Reagents
Description

Products for isolation and detection of extracellular vesicles, including precipitation solutions, SEC columns, ultracentrifugation reagents, and immunoaffinity capture beads (CD9, CD63).

18Inhibitors and Activators
CategorySmall Molecule Reagents
Description

Small molecule inhibitors and activators for research on signaling pathways and cellular processes.

19Flow Cytometry Beads
CategorySupport Products
Description

Quality control beads for calibration, compensation, and cell counting in flow cytometry experiments.

20IHC Tissue Slides
CategoryTissue Products
Description

Over 400 formalin-fixed paraffin-embedded (FFPE) and over 200 frozen tissue sections of healthy and diseased organs for immunohistochemistry controls.

21Tissue Microarrays
CategoryTissue Products
Description

Nearly 150 tissue microarrays containing 24–146 tissue samples per slide for high-throughput IHC analysis of human, rat, mouse, and primate tissue.

22Western Blot Membranes
CategorySupport Products
Description

Membranes and accessories for Western blot experiments.

23Novus Spectra Viewer
CategoryResearch Tools
Description

Web-based interactive tool for visualizing excitation and emission spectra of fluorescent probes and determining instrument configuration compatibility for multicolor experiments.

24Flow Cytometry Panel Builder
CategoryResearch Tools
Description

Interactive web tool for designing flow cytometry panels by selecting cytometer configurations, markers, and compatible fluorochrome-conjugated antibodies.

25Laverne Bioinformatics Explorer
CategoryResearch Tools
Description

Bioinformatics tool for investigating gene, pathway, and disease relationships based on co-citation analysis to guide research directions.

26Bulk and Custom Products
CategoryCustom Services
Description

Custom antibody production, bulk ordering, and custom conjugation services for specialized research needs.

Scale indicator7 records

Each record includes

Type, Value, Description, Source

Partnership1 partner
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Novus Biologicals is a brand under Bio-Techne. Products and services will transition to R&D Systems platform (rndsystems.com) by August 17, 2026. Cross-branding with other Bio-Techne brands including R&D Systems, Tocris Bioscience, ProteinSimple, and Advanced Cell Diagnostics.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight4 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

A leading U.S. antibody and reagent supplier specializing in validated antibodies for signal transduction and cancer research. Directly comparable to Novus in primary/secondary antibodies, recombinant monoclonals, and conjugated antibodies for academic and pharma researchers.

TypeDirect peer
Description

Global antibody supplier with a 100,000+ product catalog comparable to Novus's scale. Directly competes across primary antibodies, recombinant antibodies, kits, and conjugated formats; recently acquired by Danaher for ~$5.7B.

TypeDirect peer
Description

Long-established antibody supplier offering monoclonal, polyclonal, and conjugated antibodies for research applications. Directly competes with Novus in primary antibodies and supporting reagents.

TypeDirect peer
Description

Antibody manufacturer focused on rabbit monoclonal antibodies with extensive target coverage. Direct competitor in the recombinant monoclonal antibody segment where Novus competes.

TypeDirect peer
Description

Swedish antibody supplier specializing in research-grade polyclonal antibodies and tissue microarrays. Directly comparable in tissue microarray and IHC-validated antibody offerings.

TypeBroad incumbent
Description

Diversified life sciences giant with a substantial antibody and reagent portfolio (Invitrogen, Thermo Scientific brands). Overlaps with Novus across antibodies, kits, and proteins but as part of a much broader instruments-to-consumables portfolio.

TypeBroad incumbent
Description

Major life science supplier with extensive antibody, protein, and reagent catalog. Comparable to Novus's broad catalog reach but includes chemicals, labware, and bioprocessing for a much wider customer base.

TypeBroad incumbent
Description

Life science research and clinical diagnostics company offering antibodies, kits, and consumables. Overlaps with Novus in antibody products and flow cytometry reagents but operates across a broader portfolio.

TypeOthers
Description

Bio-Techne's flagship reagent brand and the platform absorbing Novus's products by August 2026. Sister brand under Bio-Techne with deep overlap in proteins, ELISA kits, and antibodies — and the destination for Novus customers post-transition.

TypeOthers
Description

Bio-Techne sister brand specializing in small molecule inhibitors/activators for neuroscience and cell signaling research. Sister-brand relationship to Novus under common Bio-Techne ownership with complementary catalog.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

Integration1 record

Each record includes

Title, Type, Description, Source

AI maturity
App detail

Has app

Feature4 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds1 record

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors1 record

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Novus Biologicals

Life Science Research Reagentsnovusbio.com

Novus Biologicals, a Bio-Techne-owned brand, sells 100,000+ life science research reagents—primarily antibodies, kits, and proteins—directly to academic, pharmaceutical, and clinical researchers worldwide, with the catalog scheduled to migrate to rndsystems.com by August 2026.

What Novus Biologicals does

Novus Biologicals, LLC is a Colorado-based life sciences research reagents company that operates as a wholly-owned brand of Bio-Techne, a diversified life sciences conglomerate. The company sells more than 100,000 products—anchored by antibodies and expanded across kits, proteins, peptides, lysates, cell lines, inhibitors, and activators—directly to researchers through its e-commerce website novusbio.com. The website is scheduled to be retired on August 17, 2026, with all products and services migrating to the parent company's R&D Systems platform at rndsystems.com. Its primary customer base is academic and research institutions, with secondary serving pharmaceutical/biotech companies and hospital/clinical laboratories.

The company's technical differentiation rests on two pillars: recombinant monoclonal antibody production technology covering 8,000+ products against 1,600+ unique targets, which immortalizes antibody sequences for batch-to-batch consistency, and the Five Pillars of Antibody Validation framework incorporating genetic knockout validation, orthogonal validation, independent antibody verification, tagged expression, and biological validation in accordance with International Working Group for Antibody Validation recommendations. Its 85,000+ conjugated antibodies cover 7,400+ targets with 25+ fluorescent and enzymatic labels, and Lightning-Link kits allow researchers to label primary antibodies in under 30 seconds hands-on time. Supporting research tools include the Spectra Viewer, Flow Cytometry Panel Builder, and Laverne bioinformatics explorer.

Commercially, Novus operates a direct-to-consumer e-commerce model complemented by phone and email sales support, an Antibody Concierge service, a global distributor network, and custom and bulk antibody production services. Revenue is generated through one-time catalog sales of research reagents with quote-based pricing that is not publicly disclosed, and products are backed by a 100% quality guarantee offering free replacement or refund. Marketing is content-led, relying on a scientific blog, free handbooks, on-demand webinars, faculty and postdoc interview series, and rewards programs (Review Rewards, Innovator's Reward, Publication Rewards, Scholarship Program). The company serves a global market via distributors, with explicit geographic focus on North America and Europe.

Novus Biologicals firmographics

Firmographics
Name
Novus Biologicals
Legal name
Novus Biologicals, LLC
Website
https://novusbio.com
Company type
Private
Founded year
1996
Operating status
Operating
Headcount range
51–100 employees
Short description
Novus Biologicals, a Bio-Techne-owned brand, sells 100,000+ life science research reagents—primarily antibodies, kits, and proteins—directly to academic, pharmaceutical, and clinical researchers worldwide, with the catalog scheduled to migrate to rndsystems.com by August 2026.
Ownership category
akta.pro rank

Novus Biologicals industry classification

Industry
Product category
Life Science Research Reagents
NAICS
Medical, Dental, and Hospital Equipment and Supplies Merchant Wholesalers (423450), Medical, Dental, and Hospital Equipment and Supplies Merchant Wholesalers (42345)
SIC
Wholesale-Medical, Dental & Hospital Equipment & Supplies (5047), Services-Commercial Physical & Biological Research (8731)
akta.pro primary industry
Reagents, Chemicals & Assay Kits (Buffers, Antibodies, ELISA, Enzymes) (HLAGAIAI)
akta.pro secondary industries
Microscopy, Imaging & Flow Cytometry Instruments (HLAGAIAE), Cell-Based & Potency Assays (Bioassays) (HLAGADAH)

Keywords

  • Research antibodies
  • Life science reagents
  • Recombinant monoclonal antibodies
  • ELISA kits
  • Antibody validation

Where Novus Biologicals is headquartered

Location

Headquarters

HQ city
Littleton
HQ country
United States
HQ region
North America

Offices1 record

Markets served

Novus Biologicals business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Supply Chain, Technology or R&D, Personnel, Marketing or Sales, Operations

Revenue model

  1. Research Reagent Product Sales: Sale of antibodies, kits, proteins, peptides, lysates, cell lines, inhibitors, activators, and support products for research applications including ELISA, flow cytometry, Western blotting, immunohistochemistry, and immunocytochemistry.

Go-to-market motion2 records

Distribution channels3 records

Marketing channels8 records

Novus Biologicals product offering

Product offering

Core offering

Novus Biologicals manufactures and distributes a catalog of more than 100,000 life science research reagents — chiefly antibodies (primary, secondary, conjugated, recombinant monoclonal, isotype control, KO-validated), proteins and peptides, ELISA kits, flow cytometry kits, ChIP kits, antibody labeling kits, lysates, cell lines, exosome isolation products, inhibitors/activators, IHC tissue slides, and tissue microarrays — sold to researchers through e-commerce, phone/email support, an international distributor network, and custom/bulk ordering services.

Product overview

Novus Biologicals is a life science reagents company offering over 100,000 products for research. The portfolio centers on antibodies—including primary antibodies, conjugated antibodies, recombinant monoclonals, secondary antibodies, and isotype controls—alongside proteins and peptides, ELISA and assay kits, and tissue products. Support offerings include exosome isolation tools, flow cytometry beads, IHC tissue slides, and tissue microarrays. Research tools include the Novus Spectra Viewer for fluorescent probe selection, Flow Cytometry Panel Builder for panel design, and Laverne bioinformatics explorer for gene/pathway/disease research. The company also provides custom/bulk ordering services and scientific resources including handbooks, protocols, webinars, and technical support. Products are backed by a 100% guarantee.

Differentiator

Problem solved

Functional benefit

Products and services

  • Primary Antibodies Monoclonal and polyclonal antibodies for detection of more than 7,400 targets, available in unconjugated and conjugated formats for research applications.
  • Conjugated Antibodies Over 85,000 primary antibodies directly conjugated to more than 25 fluorescent or enzymatic labels including Alexa Fluor, PE, FITC, and Janelia Fluor dyes for flow cytometry, ICC, IHC, and ELISA applications.
  • Recombinant Monoclonal Antibodies Over 8,000 recombinant antibody products covering more than 1,600 unique targets, produced via hybridoma conversion and B-cell cloning with immortalized sequences for batch-to-batch consistency and engineerability.
  • Secondary Antibodies Secondary antibodies for detection and signal amplification in immunoassay applications.
  • Isotype Control Antibodies Isotype control antibodies for accurate gating and background signal control in flow cytometry and other applications.
  • Sample Size Antibodies Smaller antibody quantities intended for pilot studies, testing new applications, or working with limited sample volumes.
  • Antibody Packs Pre-configured antibody sampler packs containing multiple antibodies for related targets or pathway studies.
  • Antibody Pairs Matched antibody pairs optimized for sandwich ELISA assays, including capture and detection antibodies.
  • KO Validated Antibodies Antibodies validated using CRISPR-Cas9 genetic knockout cell lines to ensure specificity and reproducibility.
  • Proteins and Peptides Recombinant proteins, native proteins, and synthetic peptides including biologically active proteins for bioactivity assays.
  • Blocking Peptides Peptides used for antibody blocking experiments to verify antibody specificity in immunostaining applications.
  • ELISA Kits Complete ELISA kits for quantitative detection of proteins and biomarkers in various sample types.
  • Flow Cytometry Kits Pre-configured kits for flow cytometry applications, including cell surface and intracellular staining panels.
  • Lightning-Link Antibody Labeling Kits Antibody conjugation kits enabling labeling of primary antibodies with more than 40 enzymatic, fluorescent, or biotin labels in under 30 seconds hands-on time.
  • ChIP Kits Chromatin immunoprecipitation kits for studying protein-DNA interactions and epigenetic modifications.
  • Lysates and Cell Lines Cell lysates and stem cell lines for research applications, including stem cell research.
  • Exosome Isolation Products Products for isolation and detection of extracellular vesicles, including precipitation solutions, SEC columns, ultracentrifugation reagents, and immunoaffinity capture beads (CD9, CD63).
  • Inhibitors and Activators Small molecule inhibitors and activators for research on signaling pathways and cellular processes.
  • Flow Cytometry Beads Quality control beads for calibration, compensation, and cell counting in flow cytometry experiments.
  • IHC Tissue Slides Over 400 formalin-fixed paraffin-embedded (FFPE) and over 200 frozen tissue sections of healthy and diseased organs for immunohistochemistry controls.
  • Tissue Microarrays Nearly 150 tissue microarrays containing 24–146 tissue samples per slide for high-throughput IHC analysis of human, rat, mouse, and primate tissue.
  • Western Blot Membranes Membranes and accessories for Western blot experiments.
  • Novus Spectra Viewer Web-based interactive tool for visualizing excitation and emission spectra of fluorescent probes and determining instrument configuration compatibility for multicolor experiments.
  • Flow Cytometry Panel Builder Interactive web tool for designing flow cytometry panels by selecting cytometer configurations, markers, and compatible fluorochrome-conjugated antibodies.
  • Laverne Bioinformatics Explorer Bioinformatics tool for investigating gene, pathway, and disease relationships based on co-citation analysis to guide research directions.
  • Bulk and Custom Products Custom antibody production, bulk ordering, and custom conjugation services for specialized research needs.

Quantifiable outcome

  • 85,000+ conjugated antibodies for over 7,400 targets
  • +2 more outcomes

Companies that use Novus Biologicals

Customer profile

Segments3 records

Ideal customer profiles3 records

Novus Biologicals technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Integration1 record

Feature4 records

Novus Biologicals partnerships and signals

Strategic signal

Partnerships

One partnership is on record.

  • Bio-TechnecoreStrategic or Co-development PartnerNovus Biologicals is a brand under Bio-Techne. Products and services will transition to R&D Systems platform (rndsystems.com) by August 17, 2026. Cross-branding with other Bio-Techne brands including R&D Systems, Tocris Bioscience, ProteinSimple, and Advanced Cell Diagnostics.

Scale indicators7 records

Recent moves6 records

Expansion highlights4 records

Novus Biologicals competitors and assessment

Company assessment

Direct peers

  • Cell Signaling Technology: A leading U.S. antibody and reagent supplier specializing in validated antibodies for signal transduction and cancer research. Directly comparable to Novus in primary/secondary antibodies, recombinant monoclonals, and conjugated antibodies for academic and pharma researchers.
  • Abcam (Danaher): Global antibody supplier with a 100,000+ product catalog comparable to Novus's scale. Directly competes across primary antibodies, recombinant antibodies, kits, and conjugated formats; recently acquired by Danaher for ~$5.7B.
  • Santa Cruz Biotechnology: Long-established antibody supplier offering monoclonal, polyclonal, and conjugated antibodies for research applications. Directly competes with Novus in primary antibodies and supporting reagents.
  • Proteintech Group: Antibody manufacturer focused on rabbit monoclonal antibodies with extensive target coverage. Direct competitor in the recombinant monoclonal antibody segment where Novus competes.
  • Atlas Antibodies: Swedish antibody supplier specializing in research-grade polyclonal antibodies and tissue microarrays. Directly comparable in tissue microarray and IHC-validated antibody offerings.

Broad incumbents

  • Thermo Fisher Scientific (Life Sciences / Antibodies): Diversified life sciences giant with a substantial antibody and reagent portfolio (Invitrogen, Thermo Scientific brands). Overlaps with Novus across antibodies, kits, and proteins but as part of a much broader instruments-to-consumables portfolio.
  • MilliporeSigma (Merck KGaA Life Science): Major life science supplier with extensive antibody, protein, and reagent catalog. Comparable to Novus's broad catalog reach but includes chemicals, labware, and bioprocessing for a much wider customer base.
  • Bio-Rad Laboratories: Life science research and clinical diagnostics company offering antibodies, kits, and consumables. Overlaps with Novus in antibody products and flow cytometry reagents but operates across a broader portfolio.

Others

  • R&D Systems (Bio-Techne): Bio-Techne's flagship reagent brand and the platform absorbing Novus's products by August 2026. Sister brand under Bio-Techne with deep overlap in proteins, ELISA kits, and antibodies — and the destination for Novus customers post-transition.
  • Tocris Bioscience (Bio-Techne): Bio-Techne sister brand specializing in small molecule inhibitors/activators for neuroscience and cell signaling research. Sister-brand relationship to Novus under common Bio-Techne ownership with complementary catalog.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

Novus Biologicals social profiles

Digital presence

Novus Biologicals financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Novus Biologicals leadership team

Management profile

Number of profiles

Novus Biologicals funding detail

Funding detail

Funding overview

Funding rounds1 record

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Novus Biologicals M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Novus Biologicals

What does Novus Biologicals do?

Novus Biologicals manufactures and distributes a catalog of more than 100,000 life science research reagents — chiefly antibodies (primary, secondary, conjugated, recombinant monoclonal, isotype control, KO-validated), proteins and peptides, ELISA kits, flow cytometry kits, ChIP kits, antibody labeling kits, lysates, cell lines, exosome isolation products, inhibitors/activators, IHC tissue slides, and tissue microarrays — sold to researchers through e-commerce, phone/email support, an international distributor network, and custom/bulk ordering services.

Is Novus Biologicals a public or private company?

Novus Biologicals is a private company. It is classified as corporate owned and is currently operating.

When was Novus Biologicals founded?

Novus Biologicals was founded in 1996. It employs 51 to 100 people.

Where is Novus Biologicals based?

Novus Biologicals is headquartered in Littleton, United States, in the North America region.

How does Novus Biologicals make money?

One revenue line is on record: research Reagent Product Sales.

Who are Novus Biologicals's main competitors?

Direct peers on record are Cell Signaling Technology, Abcam (Danaher), Santa Cruz Biotechnology, Proteintech Group and Atlas Antibodies. Broad incumbents are Thermo Fisher Scientific (Life Sciences / Antibodies), MilliporeSigma (Merck KGaA Life Science) and Bio-Rad Laboratories. Others are R&D Systems (Bio-Techne) and Tocris Bioscience (Bio-Techne).

Does Novus Biologicals have an API?

No public API is recorded for Novus Biologicals.

What industry is Novus Biologicals in?

Novus Biologicals's product category is Life Science Research Reagents. Its primary akta.pro industry code is HLAGAIAI, Reagents, Chemicals & Assay Kits (Buffers, Antibodies, ELISA, Enzymes), with a secondary code of HLAGAIAE, Microscopy, Imaging & Flow Cytometry Instruments. Its NAICS code is 423450 and its SIC code is 5047.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
PrtimesPW Consulting Forecasts Worldwide THRAP3 Antibody Market to Reach USD 20.74 Million by 2032 – PR TimesPW Consulting published a market intelligence brief forecasting the global THRAP3 antibody market to reach USD 20.74 million by 2032, with a projected compound annual growth rate (CAGR) of 5.24% during the forecast period (2026–2032). The report analyzes the competitive landscape of the niche research reagent market, profiling key players including Abcam, Santa Cruz Biotechnology, Proteintech Group, Boster Biological Technology, GeneTex, Novus Biologicals, OriGene Technologies, and Sigma-Aldrich/Atlas Antibodies. The analysis identifies recombinant antibody technologies and expanded validation offerings as critical strategic vectors for market participants seeking competitive advantage in this compact but high-value market segment.openPR.comComplement C4 Antibody Market Is Going to Boom | Merck KGaA • Novus Biologicals • GenScriptThe article reports on the global complement C4 antibody market, emphasizing its expected growth driven by rising demand and innovation, as detailed in a comprehensive market research report covering forecasts from 2026 to 2033. It highlights key companies involved, regional market sizes, and strategic insights for stakeholders.openPR.comUnited States Exosomes Market 2025: Industry Developments, Future Growth, Share & Industry Insights | Lonza, Miltenyi Biotec, Novus Biologicals, Capital Biosciences, and Bio TechneThe exosome market is projected to grow from US$259.87 million in 2024 to US$2,659.79 million by 2033, a CAGR of 29.7%. North America holds a 42.1% share in 2024, with regional news including a US acquisition and Korean clinical trial approval.PR NewswireBio-Techne Announces Commercial Release Of New Co-Detection Assays For Simultaneous Detection Of RNA And Protein On The Same SampleBio-Techne Corporation announced the commercial release of new RNA-Protein Co-Detection Assays, expanding their Advanced Cell Diagnostics (ACD)-branded RNAscope technology platform for simultaneous detection of RNA and protein on the same sample. The new assays combine the company's proprietary RNAscope and BaseScope signal amplification technologies with their extensive antibody portfolio from R&D Systems and Novus Biologicals, enabling researchers to examine cell-type specific gene expression and identify cellular sources of secreted proteins while preserving limited tissue samples. The company positioned this launch as an extension of their leadership in RNA in situ analysis into spatial multi-omics research.PR NewswireBio-Techne Leverages The RNAscope™ Technology To Advance A Multiomic Approach To Antibody ValidationBio-Techne Corporation announced it is using Advanced Cell Diagnostics' RNAscope in situ hybridization technology to validate its immunohistochemistry antibodies, combining transcriptomics with IHC for more rigorous antibody validation. The company is adopting international standards for antibody validation including genetic validation techniques sourced from B-MoGen Biotechnologies, and is applying this approach across its R&D Systems and Novus Biologicals branded antibody portfolios. GlaxoSmithKline and Johns Hopkins School of Medicine were cited as additional institutions using the RNAscope ISH platform for orthogonal antibody validation in drug discovery and research studies.